| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |